-- Preliminary Results from Duravest Subsidiary Estracure’s Phase II Clinical Trial Demonstrate that Local Administration of 17beta-Estradiol Achieves Outstanding Safety Results and Promising Efficacy Trends With Patients Who Have Undergone Coronary Angioplasty (PTCA) and Stent Implantation.
